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Chronic  pelvic  pain
Abstract
Aim:  To  assess  the  efﬁcacy  of  venous  embolization  treatment  for  the  pelvic  congestion  syndrome
(PCS).
Patients and  methods:  Retrospective  study  of  33  female  patients  undergoing  pelvic  venous
embolization  between  January  2008  and  May  2012  in  Bordeaux.  The  inclusion  criteria  were
clinical symptoms  of  PCS  documented  by  transabdominal  Doppler  ultrasound  and/or  pelvic
magnetic resonance  imaging.  Patients  with  pelvic  varicose  veins  feeding  saphenous  varicose
veins were  excluded.  The  efﬁcacy  of  treatment  was  assessed  on  a  Visual  Analog  Scale  (VAS).
Results: Thirty-three  patients  were  included  and  the  mean  follow  up  period  was  26  months
(3—59 months).  The  VAS  was  7.37  (standard  deviation:  0.99)  before  embolization  and  1.36
(standard deviation:  1.73)  after  embolization  (P  <  0.0001).  Twenty  patients  reported  that  their
symptoms  had  completely  disappeared,  11  had  partially  disappeared  and  two  had  gained
no improvement.  A  signiﬁcant  fall  was  found  in  the  number  of  patients  with  dyspareunia
(P <  0.0001).  A  single  technical  embolization  failure  was  reported.
Conclusion:  Our  series  demonstrates  the  efﬁcacy  of  embolization  treatment  with  a  signiﬁcant
fall in  the  VAS  in  patients  with  PCS.
© 2013  Éditions  franc¸aises  de  radiologie.  All  rights  reserved.
The  clinical  presentation  of  symptomatic  pelvic  venous  insufﬁciency  or  the  pelvic
congestion  syndrome  (PCS)  in  women  has  been  recognized  for  several  years  [1]  and  is
an  association  of  pelvic  pain  and  heaviness  lasting  for  more  than  6  months,  occurring  with
the  same  periodicity  as  the  menstrual  cycles,  with  dyspareunia,  dysuria  and  dysmenor-
rhea  [2].  The  presence  of  dilated  pelvic  veins  is  not  synonymous  with  PCS  [3]  and  it  is  the
incompetence  of  these  veins,  which  results  in  symptoms.  These  varicosities  can  be  fed  by
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 venous  systems,  the  gonadal  and  the  internal  iliac  veins.
enital  varicose  veins  may  be  due  to  a  gonadal  or  uterine
enous  valvular  or  wall  abnormality  but  also  to  obstructed
uprapelvic  drainage  (Nutcracker  syndrome,  thrombosis
r  congenital  variation)  or  pelvic  drainage  (May—Turner
yndrome,  extrinsic  compression  or  thrombosis).  The  combi-
ation  of  pelvic  venous  anatomy  and  anastomoses  between
he  abdominal  and  lower  limb  veins  are  such  that  a  strong
ssociation  is  seen  between  pelvic  and  lower  limb  varicose
eins  [4].  Pelvic  venous  incompetence  has  been  shown  to
orrelate  signiﬁcantly  with  pelvic  pain  [5].  Chronic  pelvic
ain  accounts  10%  of  the  gynaecological  consultations  [6]  of
hich  PCS  is  reported  to  be  the  second  leading  cause,  behind
dhesions  and  ahead  of  endometriosis  in  non-nulliparous
atients  [7].
The  aim  of  diagnostic  imaging  is  to  identify  venous  incom-
etency  (and  not  only  the  existence  of  varicose  veins)  and
o  exclude  the  differential  diagnoses  of  endometriosis,  ade-
omyosis,  cysts,  adhesions  and  inﬂammatory  diseases.  The
iagnostic  criteria  published  in  the  literature  are  a  gonadal
ein  diameter  of  over  8  mm  [8],  para-uterine  varicose  vein
iameter  over  5  mm  [9,10]  and  above  all  the  presence  of
eﬂux  during  the  Valsalva  maneuver  on  pulsed  Doppler  imag-
ng  [11,12]  and/or  on  a  dynamic  MR  angiography  [13]  or  on
hlebography.
Venous  embolization  is  currently  the  reference  treatment
or  PCS  and,  as  evidenced  by  several  publications,  is  very
ffective  on  symptoms  [5,10,14—20].
The  aim  of  this  study  was  to  assess  the  efﬁcacy  of  venous
mbolization  to  treat  PCS  in  patients  without  pelvic  vari-
osities  feeding  saphenous  varicose  veins.
aterials and methods
e  carried  out  a  retrospective  analysis  of  33  patients
aving  their  ﬁrst  pelvic  venous  embolization  between  1st
anuary  2008  and  30  May  2012  at  Bordeaux  University  Hos-
itals,  France.  Patients  with  PCS  were  included  and  each
nderwent  abdominal  and  pelvic  ultrasound  or  magnetic  res-
nance  (MR)  imaging  with  dynamic  MR  angiography.  Patients
ith  pelvic  varicosities  feeding  saphenous  varicose  veins
ere  excluded.  A  suprapubic  transabdominal  Doppler  ultra-
ound  was  used  to  identify  the  two  gonadal  veins,  measure
heir  diameter  and  establish  the  presence  or  absence  of
eﬂux  during  the  Valsalva  maneuver  and/or  from  abdominal
ressure.  The  renal  and  iliac  veins  were  investigated  rou-
inely  for  compressive  disease.  Pelvic  varicose  veins  were
dentiﬁed  and  their  diameter  was  measured  by  suprapubic
elvic  ultrasound.  Perineal  ultrasound  was  used  as  applica-
le  to  conﬁrm  or  exclude  perineal  and  vulval  varicose  veins,
hich  are  often  symptomatic.  MR  was  performed  on  a  1.5  T
nstrument  (Advento,  Siemens)  and  involved  T2-weighted
elvic  sequence  with  fat  saturation  in  the  3  spatial  planes,
 T1-weighted  axial  image  with  fat  saturation  before  and
fter  Gadolinium  chelate  enhancement  and  coronal  dynamic
R  angiography  (Twist)  was  used  to  conﬁrm  the  presence
f  pelvic  varicose  veins  or  reﬂux  in  the  gonadal  veins  and
xclude  the  differential  diagnoses.  Diagnostic  phlebography
ollowed  by  a  single  stage  embolization  was  organized  on
n  ambulatory  basis  and  was  carried  out  under  transdermal
ocal  anesthesia  with  2  mL  of  lidocaine  followed  by  a  brachial
N
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enous  approach  through  an  18  G  needle  and  a  0.035,  180  cm
ong  hydrophilic  guide.  A  5-Fr,  11  cm  Désilet  catheter  was
hen  introduced  and  phlebography  was  performed  to  exam-
ne  the  three  venous  systems,  the  gonadal  veins,  the  internal
liac  venous  system  and  its  afferent  vessels  (particularly,  the
udendal  and  internal  obturator  veins)  and  the  left  external
liac  system.  A  5-Fr  HH1  catheter  was  used  to  catheterize
he  right  renal  vein  followed  by  phlebography  with  a  Val-
alva  maneuver  to  investigate  for  ovarian  vein  varicocele.
ncompetent  segments  were  localized  by  ovarian  vein  and
elvic  varicose  vein  phlebography  with  opaciﬁcation  dur-
ng  a  Valsalva  maneuver  or  coughing.  The  same  procedure
as  carried  out  on  the  right  side.  Bilateral  phlebography
as  performed  on  the  internal  iliac  veins  and  their  affer-
nt  vessels,  with  opaciﬁcation  during  a  Valsalva  maneuver
r  coughing.  In  many  cases,  a  microcatheter  was  needed
o  examine  the  afferent  internal  iliac  vessels.  Left  inter-
al  iliac  phlebography  was  performed  (examining  for  the
ockett  syndrome)  and  leakage  points  were  embolized  by
auromacrogol  sclerosant  in  microfoam  form  (2%  Aetoxyscle-
ol)  and  coils,  occasionally  combined  with  the  insertion
f  a  plug.  If  a  second  embolization  session  was  required
or  the  afferent  internal  iliac  system,  a  femoral  venous
pproach  was  used.  After  embolization,  the  patients  were
iven  step  1  analgesics  and  anti-inﬂammatory  drugs.  They
ere  reassessed  clinically  and  by  MR  at  three  months.  All  the
atients  were  contacted  by  telephone  to  record  the  recent
ndings.
The  primary  end  point  for  efﬁcacy  of  treatment  was  a
isual  Analogue  Scale  (VAS).  The  secondary  end  points  were
he  patients’  opinion  of  whether  or  not  they  had  beneﬁted
rom  treatment  and  the  change  in  their  main  symptoms  (dys-
areunia  and  dysuria).
tatistics
he  Student  t-test  was  used  to  compare  normally  dis-
ributed  variables  and  the  Wilcoxon  test  for  non-parametric
ariables.  P  values  of  less  than  0.05  were  deemed  to  be
tatistically  signiﬁcant.
esults
haracteristics of the population included
ur  study  population  consisted  of  33  patients  with  PCS
eferred  by  their  gynaecologist.  No  patients  had  venous
eturn  obstruction  (Nutcracker  or  May—Turner  syndromes).
wenty-nine  of  the  33  patients  had  ovarian  and  pelvic  venous
ltrasound  and  abdomino-pelvic  MR.  Four  patients  were
nvestigated  only  by  Doppler  ultrasound,  two  because  of
ontraindications  to  MR  (foreign  body  and  claustrophobia).
n  each  occasion,  a  dilated  reﬂuxing  left  gonadal  vein  or
elvic  varicose  veins  >  5  mm  were  found.  The  characteristics
f  the  population  are  summarized  in  Table  1.
esults of embolizationo  deﬁnitive  technical  failures  occurred  and  only  one
atient  required  repeat  treatment  because  of  an  inabil-
ty  to  catheterize  the  left  ovarian  vein  during  the  ﬁrst
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Table  1  Characteristics  of  the  population  included.
Number  of  patients  included  33
Average  age  (years)  (standard
deviation)
41.4  (20—65)
Average  number  of  pregnancies
(standard  deviation)
2.15  (0—5)
Past  history  of  DVT/PE  3
Hysterectomy  2
Surgery  for  lower  limb  venous
insufﬁciency
6
Pelvic  pain  >  6  months  32  (97%)
Dyspareunia  20  (60%)
Vulval  varicose  veins 11  (33%)
Lower  limb  varicose  veins  13  (39%)
Table  2  Topography  of  embolized  veins.
Embolized  pelvic  veins  Number
of  cases
Left  ovarian  vein  17
Right  ovarian  vein  2
Left  internal  iliac  vein  and  its  afferent
branches
1
Right  iliac  vein  and  its  afferent  branches 1











NGVV.  No  recanalization  of  embolized  veins  were  recordedDysuria  2  (6%)
embolization  attempt.  Each  incompetent  vein  was
embolized.  The  distribution  of  veins  embolized  in  the
ﬁrst  session  is  shown  in  Table  2.  One  patient  had  bilateral
ovarian  vein  incompetence  (VI)  and  another  had  bilateral
incompetence  of  the  internal  iliac  vein  or  its  afferent
vessels.  According  to  the  M.  Greiner  classiﬁcation  [21],
the  population  included  18  cases  of  genital  varicose  veins
(arising  from  the  gonadal  veins),  one  case  of  non-genital




Figure 1. Phlebography showing mixed varicose veins. a: incompeten
iliac venous system; c: complete occlusion of the left ovarian vein with c
internal iliac veins by coils.branches
enous  system)  and  14  cases  of  mixed  varicose  disease
Fig.  1).  Four  of  the  33  patients  required  one  further
mbolization  and  two  required  two  further  embolizations.
he  average  time  to  recurrence  of  symptoms  of  pain  leading
o  further  treatment  was  eight  and  a  half  months  (range:
—12  months).  Four  cases  of  genital  varicose  veins  (GVV)
eccured  as  non-genital  varicose  veins  (NGVV)  (Fig.  2).  One
ase  of  GVV  recurred  due  to  the  incompetence  of  the  con-
ralateral  gonadal  vein.  One  mixed  varicose  vein  recurred
ontralaterally  in  the  same  way  and  one  recurred  as  an  the  MRI  control  at  3  months  and  in  subsequent  phlebo-
raphies  performed  because  of  clinical  recurrence.  Two
omplications  were  seen.  One  was  coil  migration  into  the
ce of the left ovarian vein; b: incompetence of the right internal
oils and a sclerosing agent; d: occlusion of the afferent reﬂux right
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teft ovarian vein embolized with coil and sclerosant; c: non-genita
liac veins; d: coil embolization of the left internal iliac venous syst
ulmonary  arterial  venous  system  with  no  haemodynamic
r  respiratory  consequences.  The  coil  was  left  in  place,  as
t  was  located  very  distally.  The  second  was  a  left  internal
liac  vein  thrombosis  following  embolization  of  the  left
varian  vein,  which  caused  severe  pain.  The  patient  was
nti-coagulated  for  two  and  a  half  months  and  the  venous
ystem  recanalized  and  showed  no  obvious  complications
n  repeat  MR.
An  average  105  mL  of  the  contrast  medium  was  used
uring  the  one  stage  phlebography  and  embolization.  The
verage  radioscopy  time  was  24.5  min  and  the  average  dose
urface  area  product  was  103.2  Gy·cm−2.
rimary  end  point  results
verage  patient  follow  up  was  26  months  (3—59  months)  with
 median  of  23  months.  The  average  VAS  before  emboliza-
ion  was  7.37  (standard  deviation,  0.99)  compared  to  1.36




vcose recurrence due to incompetence to the afferent left internal
wenty  patients  reported  that  their  symptoms  had  disap-
eared  completely,  11  had  partially  disappeared  and  two
ad  not  improved.  There  were  no  signiﬁcant  differences
etween  VAS  between  the  GVV  and  mixed  varicose  vein  sub-
roups  before  (P  >  0.1)  or  after  (P  >  0.3)  embolization.
econdary  end  point  results
e  found  a signiﬁcant  fall  in  the  number  of  patients  with
yspareunia  (P  <  0.0001).  Seventeen  (85%)  of  the  20  patients
ith  dyspareunia  reported  that  their  symptoms  had  dis-
ppeared.  There  was  no  statistical  difference  between
he  number  of  patients  complaining  of  dyspareunia  in
he  two  subgroups  before  (P  =  0.1)  and  after  embolization
P  >  0.4).  Two  patients  had  dysuria,  symptoms  of  which  were
nchanged  after  embolization.  Changes  in  the  VAS  and  dys-
areunia  in  the  two  subgroups  (genital  and  mixed  varicose
eins)  are  shown  in  Table  3.
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Table  3  Change  in  VAS  and  dyspareunia  in  the  subgroup  with  genital  and  mixed  varicose  veins.
Before  embolization  After  embolization  P  value
Genital  varicose  vein  group
VAS  (mean  ±  SD)  7.33  ±  0.9  1.55  ±  1.69  <  0.0002
Dyspareunia  (n)  9  1  <  0.006
Mixed  varicose  vein  group









































PDyspareunia  (n) 11  
Discussion
Our  study  shows  that  pelvic  venous  embolization  is  tech-
nically  extremely  successful  (1  single  temporary  failure  of
catheterization),  and  very  effective  in  93%  of  the  cases,
including  85%  of  the  patients  in  whom  dyspareunia  had  dis-
appeared  after  an  average  follow  up  of  26  months.
The  main  limitation  of  our  study  was  that  it  was  ret-
rospective  and  on  small  numbers  although  no  patients
were  lost  to  follow  up.  We  did  not  speciﬁcally  study  post-
embolization  pain  because  of  a  lack  of  standardized  data
collection.  This  is  an  important  feature  as  it  is  almost  the
only  discomfort  caused  by  treatment  of  PCS.
Comparison of our ﬁndings on the
embolization technique with those reported
in the literature
Several  publications  describe  difﬁculties  catheterizing  the
right  ovarian  vein  (ROV)  [5].  The  main  beneﬁt  of  the  brachial
approach  is  that  a  single  catheter  is  used  to  catheter-
ize  all  of  the  main  veins,  which  are  to  be  investigated
and  embolized.  This  appears  to  reduce  right  ovarian  vein
catheterization  failures.  Some  authors  recommend  a  left
femoral  vein  approach  if  ROV  catheterization  fails  [10]
although  several  series  using  the  right  femoral  approach  only
do  not  report  any  catheterization  failure  [14].
Like  other  groups  [20,22],  we  combine  foam  sclerosant
with  coils  as  the  embolization  method.  Foam  sclerosant  is
recommended  as  the  embolization  agent  for  proximal  treat-
ment  of  veins  compared  to  a  pure  liquid  sclerosant  [23].
Although  no  studies  have  shown  the  use  of  coils  alone  to  be
superior  to  coils  with  a  sclerosant  or  other  liquid  emboliza-
tion  agent,  foam  sclerosis  has  the  advantage  of  spreading
more  readily  into  all  of  the  venous  collaterals  and  increas-
ing  the  treatment  surface  area  on  the  venous  endothelium
with  a  small  amount  of  sclerosant,  particularly,  if  concom-
itant  venous  dysplasia  is  present.  Distal  occlusion  of  the
large  venous  trunks  is  supplemented  by  coils.  We  found  no
minor  side  effects  from  using  the  sclerosant  although  these
are  recognized  (allergy,  headaches,  dizziness).  The  case  of
internal  iliac  vein  thrombosis  in  our  series  may  be  due  to
the  sclerosant,  just  as  deep  vein  thrombosis  being  a  classi-
cal  complication  of  treatment  for  lower  limb  varicose  veins.
The  case  of  coil  migration  in  our  series  is  a  rare  complica-
tion  [5,14,17,24]  and  often  has  no  consequences,  as  these
can  be  removed  endovascularly  in  the  same  procedure.
The  irradiation  received  by  patients  during  the  emboliza-




a2  <  0.004
he  doses  delivered  for  lower  limb  arteriography,  coro-
ary  angiography  with  angioplasty  or  diagnostic  cerebral
rteriography  and  appears  to  be  far  lower  than  the  doses
elivered  during  uterine  embolization  according  to  the
rench  National  Institute  for  Radiation  Protection  and
uclear  Safety  (IRSN).  We  found  little  information  about
osimetry  for  PCS  venous  embolization  in  published  series
lthough  the  Laborda  series  reports  a  lower  exposure  level
f  72  Gy·cm−2[14].
omparison of clinical efﬁcacy to results
ublished in the literature
ur  treatment  goal,  based  on  the  recommendations  from
he  French  Society  for  Diagnostic  and  Interventional  Car-
iac  and  Vascular  Imaging  in  2007,  is  only  to  occlude  the
iseased  segments,  a  principle  which  is  described  in  other
tudies  [25].  Some  authors,  however,  report  that  gonadal
ein  embolization  is  sufﬁcient  to  be  effective  although
hese  data  are  based  on  a  very  small  number  of  patients
26,27].  The  pathophysiological  principle  of  PCS,  which
s  similar  to  communicating  vessels,  is  such  that  of  the
iseased  segments  need  to  be  treated.  Some  authors  go
urther,  recommending  routine  embolization  of  both  ovar-
an  and  internal  iliac  veins  [14,28].  These  authors’  series
how  excellent  clinical  efﬁcacy  (>  85%)  without  recurrences.
he  clinical  efﬁcacy  in  our  series  was  similar  to  those  pub-
ished  [5,10,14—18,29], in  which  pain  and  dyspareunia  often
mprove.
The  recurrence  rate  is  difﬁcult  to  assess.  In  several
ublications,  treatment  was  deemed  to  be  ineffective  if
igniﬁcant  improvement  was  not  reported  after  the  ﬁrst
mbolization  session.  Our  series  suggest  that  there  is  a  ten-
ency  for  recurrence  in  veins,  which  are  not  embolized.
ome  publications  report  a  recurrence  rate  of  up  to  42%
15]  although  the  term  recurrence  is  debatable.  We  did  not
nd  any  cases  of  recurrence  at  embolized  sites  in  our  series
ut  rather  failure  of  the  venous  system  on  which  increased
emand  is  placed  as  a  result  of  treating  other  diseased  sites.
his  highlights  the  complex  pathophysiological  nature  of  PCS
nd  the  need  for  regular  follow  up  after  treatment.
In  conclusion,  the  results  of  our  study  are  consistent  with
hose  published  in  larger  series,  which  show  embolization
reatment  to  be  effective  with  few  side  effects  provided.
ractitioners  understand  the  use  of  the  various  imaging
ethods  to  select  the  population  of  women  who  will  bene-
t  from  it.  A  good  understanding  of  the  pathophysiology  of
enous  reﬂux  disease  and  skill  in  embolization  techniques
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